<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 21 May 2026 07:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Reports 2026 Second Quarter Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;Reports Strong Revenue, Gross Margin, and Income Growth&lt;/b&gt;

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Details Exciting Progress on Contamination Prevention Category Creation&lt;/b&gt;

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;amp;esheet=54539720&amp;amp;newsitemid=20260521135285&amp;amp;lan=en-US&amp;amp;anchor=www.sedarplus.ca&amp;amp;index=1&amp;amp;md5=15e5d90583d7e6a8fcde2d22e888f7aa&quot; shape=&quot;rect&quot;&gt;www.sedarplus.ca&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s second quarter of fiscal 2026 demonstrated strong year-over-year revenue growth of 15%, led by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Covalon+Reports+2026+Second+Quarter+Results/26531274.html</guid>
   <pubDate>Thu, 21 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.35171336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41160441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42844528</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08071023</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13287785</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52999085</category>
   	  </item>
  <item>
   <title>Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Second+Quarter+Fiscal+2026+Results/26493012.html</link>
   <description>
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the &quot;Company&quot; or &quot;Covalon&quot;) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET.

&lt;/p&gt;&lt;p&gt;
To view, listen to, and participate in the live webcast, please follow the link below:

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F485973962&amp;amp;esheet=54536266&amp;amp;newsitemid=20260514447865&amp;amp;lan=en-US&amp;amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F485973962&amp;amp;index=1&amp;amp;md5=89f1c9aca742a8bed5f6185e98bc5bba&quot; shape=&quot;rect&quot;&gt;https://events.q4inc.com/attendee/485973962&lt;/a&gt;

&lt;/p&gt;&lt;p&gt;
To listen and participate via the conference call, please dial:

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
USA Toll-Free: 1-800-715-9871
&lt;br /&gt;Canada Toll-Free: 1-800-715-9871
&lt;br /&gt;Local (Toronto): 647-932-3411
&lt;br /&gt;Conference ID: 4934172

&lt;/p&gt;&lt;p&gt;
Participants will be able</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Second+Quarter+Fiscal+2026+Results/26493012.html</guid>
   <pubDate>Thu, 14 May 2026 13:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	  </item>
  <item>
   <title>Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Second+Quarter+Fiscal+2026+Results/26493012.html</link>
   <description>
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the &quot;Company&quot; or &quot;Covalon&quot;) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET.

&lt;/p&gt;&lt;p&gt;
To view, listen to, and participate in the live webcast, please follow the link below:

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F485973962&amp;amp;esheet=54536266&amp;amp;newsitemid=20260514447865&amp;amp;lan=en-US&amp;amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F485973962&amp;amp;index=1&amp;amp;md5=89f1c9aca742a8bed5f6185e98bc5bba&quot; shape=&quot;rect&quot;&gt;https://events.q4inc.com/attendee/485973962&lt;/a&gt;

&lt;/p&gt;&lt;p&gt;
To listen and participate via the conference call, please dial:

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
USA Toll-Free: 1-800-715-9871
&lt;br /&gt;Canada Toll-Free: 1-800-715-9871
&lt;br /&gt;Local (Toronto): 647-932-3411
&lt;br /&gt;Conference ID: 4934172

&lt;/p&gt;&lt;p&gt;
Participants will be able</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Second+Quarter+Fiscal+2026+Results/26493012.html</guid>
   <pubDate>Thu, 14 May 2026 13:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	  </item>
  <item>
   <title>Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Second+Quarter+Fiscal+2026+Results/26493012.html</link>
   <description>
&lt;p&gt;    MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Covalon Technologies Ltd. (the &quot;Company&quot; or &quot;Covalon&quot;) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET.

&lt;/p&gt;&lt;p&gt;
To view, listen to, and participate in the live webcast, please follow the link below:

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F485973962&amp;amp;esheet=54536266&amp;amp;newsitemid=20260514447865&amp;amp;lan=en-US&amp;amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F485973962&amp;amp;index=1&amp;amp;md5=89f1c9aca742a8bed5f6185e98bc5bba&quot; shape=&quot;rect&quot;&gt;https://events.q4inc.com/attendee/485973962&lt;/a&gt;

&lt;/p&gt;&lt;p&gt;
To listen and participate via the conference call, please dial:

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
USA Toll-Free: 1-800-715-9871
&lt;br /&gt;Canada Toll-Free: 1-800-715-9871
&lt;br /&gt;Local (Toronto): 647-932-3411
&lt;br /&gt;Conference ID: 4934172

&lt;/p&gt;&lt;p&gt;
Participants will be able</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Second+Quarter+Fiscal+2026+Results/26493012.html</guid>
   <pubDate>Thu, 14 May 2026 13:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVALF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01582705</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	  </item>
 </channel>
</rss>
